InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-3.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Garipalli Vivek, Director. Insider active across 1 company, notably Clover Health Investments, CORP. /de. In total, 9 reports have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €3.4m. Activity tracked since 17 June 2024. The latest transaction was disclosed on 7 August 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
415,000 shares@ US$2.2450.0% of flowClass A Common StockSEC:0001801170-25-000207
Ideal exit: 4 May 2026 (T+270)
415,000 shares@ US$2.240.065% mcap50.0% of flowClass A Common StockSEC:0001801170-25-000207:0
Ideal exit: 4 May 2026 (T+270)
1,670,965 shares0Class A Common StockSEC:0001801170-25-000027:0
531,700 shares@ US$1.8826.6% of flowClass A Common StockSEC:0001801170-24-000172:0
Ideal exit: 6 May 2025 (T+270)
877,567 shares@ US$1.1427.1% of flowClass A Common StockSEC:0001801170-24-000132:0
Ideal exit: 14 Mar 2025 (T+270)
1,561,065 sharesClass A Common StockSEC:0001801170-24-000039:0
1,569,594 sharesClass A Common StockSEC:0000895345-23-000261:0
3,342,698 sharesClass B Common StockSEC:0001628280-22-000730
3,342,698 sharesClass B Common StockSEC:0001628280-22-000730:0
9 of 9 declarations
About Garipalli Vivek
Vivek Garipalli is a Director and Chief Executive Officer of Clover Health Investments, Corp. /DE. He leads the company with a focus on strategy and growth. His experience in the health sector is an asset for developing innovative solutions.
